V
ViCentra
Discreet, automated insulin patch pump system.
About ViCentra
Kaleido, operating under the website hellokaleido.com, is a healthcare startup that provides innovative solutions for individuals living with diabetes. The company's primary product is a compact, wearable insulin pump that offers flexibility and convenience to its users. The pump is designed to hold 200 units of rapid-acting insulin, with a battery life of three days, and can be worn underwater for up to an hour.
Kaleido's target market is individuals with diabetes who require insulin therapy. The company operates in the healthcare sector, specifically within the diabetes management market. The business model is centered around providing a product that offers a more convenient and flexible alternative to traditional insulin pumps.
Kaleido makes money by selling its insulin pumps to patients. The pumps are prescribed by healthcare professionals who believe insulin pump therapy is a suitable treatment option for their patients. The company's unique selling proposition is its micro pulse technology, which ensures consistent insulin delivery, and its easy-to-apply infusion sets, which are designed to make the process of using the pump as straightforward as possible.
In summary, Kaleido is a healthcare startup that offers an innovative, user-friendly solution for individuals requiring insulin therapy. Its product is designed to make living with diabetes more manageable, providing users with the freedom and flexibility to live their lives without the constraints of traditional insulin pumps.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2013
- Headquarters
- Utrecht, Netherlands
- Employees
- 202
- Open positions
- 24
- Dealroom signal
- 92.0/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Diabetes, Remote Monitoring, Tech for Patients, Horizon Europe, Digital Care, remote health monitoring, DT and LS, science-based
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES DOther financing | Jan 2026 | $12M | $400M | Innovation Industries · ROM Utrecht Region - Regional Development Agency · VENTURING TECH | ↗ |
| SERIES DOther financing | Sep 2025 | $80M | $321M | Health Innovations · Partners in Equity (PiE) · EQT Life Sciences · Invest-NL | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for ViCentra is 7.9K monthly website visits, down 28.2% over the last three months. ViCentra's team grew 17.4% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
DiabeloopMedical device company for diabetes and closed-loop system and also develops disruptive technological innovations to automate the treatment of diabetes |
Grenoble, France | Operational | 77 | $149M | $400M |
Bluedrop MedicalHealthcare Connected |
Galway, Ireland | Operational | |||
FeetMeProposing a medical device connected to pressure sensors soles |
Paris, France | Operational | |||
BiovotionWearable physiology monitoring company |
London, United Kingdom | Acquired | |||
Indigo DiabetesDevelops invisible sensors for people living with diabetes |
Ghent, Belgium | Operational | |||
Pulsify MedicalWearable ultrasound patches for continuous cardiac monitoring |
Leuven, Belgium | Operational | |||
SleepizProvides patient-centric disease management through seamless integration of contactless monitoring into people’s homes |
Zurich, Switzerland | Operational | |||
BytefliesWearable medical devices for remote patient monitoring |
Antwerp, Belgium | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Inkef
Health Innovations
EQT Life Sciences
Series B and later7 investors entered at this stage
Kreos Capital
Invest-NL
Partners in Equity (PiE)
Lsp
Innovation Industries
ROM Utrecht Region - Regional Development Agency
VENTURING TECH
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about ViCentra on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ViCentra’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







